Back to Results

Fresenius Medical Care Corporation (FMS)

Fresenius Medical Care Corporation (NYSE: FMS) is a depositary receipt representing common stock of Fresenius Medical Care AG, a healthcare company focused on dialysis and related services for people with renal disease. Through its Care Delivery and Care Enablement segments, the company provides dialysis treatment, laboratory and diagnostic services, patient support, and hospital-based dialysis services in the United States for patients with end-stage renal disease or acute kidney failure. It also develops, manufactures, and distributes kidney care products such as hemodialysis machines, peritoneal dialysis systems and solutions, bloodlines, renal pharmaceuticals, and water-treatment systems. The company serves customers in Germany, the United States, and other international markets, with products and services sold through clinics, hospitals, distributors, and direct sales channels. Fresenius Medical Care AG was incorporated in 1996 and is headquartered in Bad Homburg, Germany.


Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ

Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Dividend Yield P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
NYSE-FMS
$29.81
31.5% Upside
Undervalued
$23.82
5.0% Upside
Fair
Great
2.7%
11.4x
0.9x
0.6x
12.004 B
23.928 B
48.7%
74.6%
7.6
42.7%
190.3%
Valuation • Fair Value

Fresenius Medical Care Corporation (NYSE-FMS) Fair Value by Valuation Model

Review the available estimates for Fresenius Medical Care Corporation (NYSE-FMS), including DCF Fair Value, Ben Graham Formula Value, DDM Fair Value, EPV Fair Value, Comps Fair Value.

Primary Valuation Read

Fair Value

$29.81

Estimated upside of 31.5% versus the current market price.

Fair Value Confidence

High

Confidence level for the primary fair value estimate.

DCF Fair Value

$42.37

Discounted cash flow valuation reference.

Ben Graham Formula Value

$22.25

Classic Ben Graham valuation formula reference.

DDM Fair Value

$19.03

Dividend discount model valuation reference.

EPV Fair Value

$13.27

Earnings power value estimate.

Comps Fair Value

$27.80

Comparable-company valuation reference.

Analyst Price Target

$23.82

Analysts imply upside of 5.0%.

How to read these valuation models

Use the 8 available valuation references for Fresenius Medical Care Corporation (NYSE-FMS) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for Fresenius Medical Care Corporation (NYSE-FMS)

Review the profitability and growth indicators currently supported by the latest data.

Revenue

22.185 B

Current operating scale indicator.

Revenue Forecast

32.063 B

Forward revenue estimate.

EBITDA

3.108 B

Current operating profitability reference.

EBITDA Forecast

3.845 B

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Fresenius Medical Care Corporation (NYSE-FMS) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Fresenius Medical Care Corporation (NYSE-FMS)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Great

Positive financial-health read.

Piotroski Score

7

Relatively strong quality score.

Beneish M-Score

-2.76

No elevated caution signal from this screen.

Altman Z-Score

7.6

Relatively strong balance-sheet zone.

FCF / Net Income

190.3%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Fresenius Medical Care Corporation (NYSE-FMS). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Dividend Profile for Fresenius Medical Care Corporation (NYSE-FMS)

Review the dividend metrics currently supported by the latest data.

Dividend Yield

2.7%

Current income yield reference.

Payout Ratio

42.7%

Dividend payout reference.

How to read events and dividends

Review the currently available dividend data for Fresenius Medical Care Corporation (NYSE-FMS). No upcoming company event date is included in the latest data.

Stock Forecast • Technical Outlook

Fresenius Medical Care Corporation (NYSE-FMS) Stock Forecast & Technical Outlook

Review Fresenius Medical Care Corporation (NYSE-FMS) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Buy

The 15-minute technical read for Fresenius Medical Care Corporation (NYSE-FMS) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Buy

The 1-hour technical read for Fresenius Medical Care Corporation (NYSE-FMS) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Buy

The daily technical read for Fresenius Medical Care Corporation (NYSE-FMS) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Sell

The weekly technical read for Fresenius Medical Care Corporation (NYSE-FMS) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Sell

The monthly technical read for Fresenius Medical Care Corporation (NYSE-FMS) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Fresenius Medical Care Corporation (NYSE-FMS)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Hold

Based on the available recommendation mix, Fresenius Medical Care Corporation (NYSE-FMS) has a Hold consensus, with 1 buy, 3 hold and 1 sell recommendations in the current data set.

Buy 1
Hold 3
Sell 1
FAQ • Fast Investor Answers

Fresenius Medical Care Corporation (NYSE-FMS) Stock FAQ

Data-supported answers about Fresenius Medical Care Corporation (NYSE-FMS), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
$29.81
Estimated upside 31.5%
Valuation Rating
Undervalued
Estimated upside of 31.5%
Analyst Target
$23.82
Implied upside 5.0%
Financial Health
Great
Current financial-health read

The current fair value estimate for Fresenius Medical Care Corporation (NYSE-FMS) is $29.81. This implies an estimated upside of 31.5% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 31.5% versus the current market price.

The available analyst price target for Fresenius Medical Care Corporation (NYSE-FMS) is $23.82. The analyst target implies estimated upside of 5.0%.

The current financial health read for Fresenius Medical Care Corporation (NYSE-FMS) is Great. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

Based on the current data, dividend yield is 2.7%.

The current P/E ratio listed for Fresenius Medical Care Corporation (NYSE-FMS) is 11.4x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for Fresenius Medical Care Corporation is 12.004 B.

The current enterprise value listed for Fresenius Medical Care Corporation is 23.928 B. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Fresenius Medical Care Corporation is NYSE-FMS, and the stock is listed on NYSE.

Fresenius Medical Care Corporation (NYSE-FMS) is listed on NYSE.

The current debt-to-total-capital ratio listed for Fresenius Medical Care Corporation is 48.7%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Fresenius Medical Care Corporation is 74.6%. Free float helps investors understand how much of the share base is available for public trading.

Similar Healthcare Providers & Services Stocks View more on NYSE

Comparable companies from the same industry, limited to one security per issuer.

UNH NYSE Unitedhealth Group Fair Value Undervalued Market Cap 375.3 B
CVS NYSE CVS Health Corp Fair Value Undervalued Market Cap 119.5 B
MCK NYSE McKesson Corporation Fair Value Fair Market Cap 116.7 B
HCA NYSE HCA Holdings Inc Fair Value Fair Market Cap 101.5 B
ELV NYSE Elevance Health Inc Fair Value Fair Market Cap 95.054 B
CI NYSE Cigna Corp Fair Value Bargain Market Cap 81.109 B
COR NYSE Cencora Inc Fair Value Fair Market Cap 63.164 B
CAH NYSE Cardinal Health Inc Fair Value Fair Market Cap 57.79 B
HUM NYSE Humana Inc Fair Value Fair Market Cap 50.682 B
CNC NYSE Centene Corp Fair Value Fair Market Cap 34.664 B
DGX NYSE Quest Diagnostics Incorporated Fair Value Fair Market Cap 26.698 B
LH NYSE Labcorp Holdings Inc Fair Value Fair Market Cap 26.678 B
GH NASDAQ Guardant Health Inc Fair Value Overvalued Market Cap 22.69 B
THC NYSE Tenet Healthcare Corporation Fair Value Fair Market Cap 21.615 B
BTSG NASDAQ Brightspring Health Services Inc Fair Value Fair Market Cap 12.526 B
EHC NYSE Encompass Health Corp Fair Value Fair Market Cap 12.242 B
DVA NYSE DaVita HealthCare Partners Inc Fair Value Fair Market Cap 11.711 B
UHS NYSE Universal Health Services Inc Fair Value Undervalued Market Cap 11.015 B
MOH NYSE Molina Healthcare Inc Fair Value Undervalued Market Cap 10.895 B
ENSG NASDAQ The Ensign Group Inc Fair Value Fair Market Cap 10.148 B